| View |
|
DRP-8138-03
|
Tobramycin
|
IKSHATOB
|
3 mg/mL (0.3% w/v)
|
Ophthalmic Solution (Drops)
|
Anti-infectives
|
Daewoo Pharm. Co. Ltd.
|
Korea
|
Renewal
|
29 June 2024
|
31 October 2029
|
| View |
|
DRP-8263-12
|
Mupirocin
|
Bactrodix
|
20 mg/g (2% w/w)
|
Ointment
|
Antibacterial
|
Magbro Healthcare Pvt. Ltd
|
India
|
Renewal
|
11 June 2024
|
10 July 2029
|
| View |
|
DRP-8473-01
|
Ceftazidime (as Pentahydrate)
|
KERAZINE
|
1 g
|
Powder for Injection
|
Antibacterial ( Third Generation Cephalosporin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd
|
China
|
CLIDP Conversion
|
08 April 2024
|
16 July 2029
|
| View |
|
DRP-8634-06
|
Paracetamol + Caffeine
|
Erapam
|
500 mg/65 mg
|
Tablet
|
Analgesic/ Antipyretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
23 April 2024
|
16 January 2025
|
| View |
|
DRP-8727-06
|
Cetirizine Hydrochloride
|
Zebzine
|
10 mg
|
Film-Coated Tablet
|
Antihistamine
|
ACME Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 April 2024
|
12 February 2025
|
| View |
|
DRP-8929-15
|
Norepinephrine (as bitartrate)
|
Noremin
|
1mg / mL (4 mg/4 mL and 10 mg / 10 mL)
|
Solution for Injection (I.V.)
|
Adrenergic/Dopaminergic Agent
|
BCWorld Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
25 April 2024
|
29 June 2025
|
| View |
|
DRP-9244-10
|
Salbutamol (as sulfate)
|
Selbronx
|
1 mg/mL (2.5 mg/2.5 mL)
|
Solution for Inhalation
|
Bronchodilator (Selective beta-2-adrenoreceptor agonist)
|
Legency Remedies Pvt. Ltd
|
India
|
CLIDP Conversion
|
15 April 2024
|
09 June 2025
|
| View |
|
DRP-9314-06
|
Rosuvastatin (as calcium)
|
Goroztin-10
|
10 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 April 2024
|
25 November 2025
|
| View |
|
DRP-9407
|
Tropisetron Hydrochloride
|
None
|
5 mg/5 mL
|
Solution for IV Injection
|
5-HT3 Receptor Antagonist
|
Qilu Pharmaceutical Co., Ltd
|
China
|
Renewal
|
28 April 2024
|
19 February 2030
|
| View |
|
DRP-9415-04
|
Iohexol
|
Hexolin 350
|
755 mg/mL (eq. to 350 mg/mL Iodine)
|
Solution for Injection (Intravascular/Intraarticular/Oral or Rectal Administration/Oral in Conjunction with Intravenous Administration/Body Cavity)
|
X-ray Contrast Media, Iodinated (Watersoluble, Neprotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 April 2024
|
23 December 2025
|
| View |
|
DRP-9416-04
|
Iohexol
|
Prohexon 300
|
647 mg/mL (eq. to 300 mg/mL Iodine)
|
Solution for Injection (Intrathecal/Intravascular/Intraarticular/Oral or Rectal Administration/Oral in conjunction with Intraveous Administration/Body cavity)
|
X-ray Contrast Media, Iodinated (Watersoluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 April 2024
|
23 December 2025
|
| View |
|
DRP-9416-05
|
Iohexol
|
Hexolin 300
|
647 mg/mL (eq. to 300 mg/mL Iodine)
|
Solution for Injection (Intrathecal/Intravascular/Intraarticular/Oral or Rectal Administration/Oral in Conjunction with Intravenous Administration/Body Cavity)
|
X-ray Contrast Media, Iodinated (Watersoluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 April 2024
|
23 December 2025
|
| View |
|
DRP-9896-06
|
Budesonide
|
Budehil
|
250 mcg/ mL (500 mcg/ 2mL)
|
Suspension for Nebulization
|
Corticosteroid
|
AXA Parenterals Ltd
|
India
|
CLIDP Conversion
|
18 April 2024
|
24 June 2025
|
| View |
|
DRP-9921-03
|
Sevoflurane
|
Sevorizz
|
100 %
|
Volatile Liquid for Inhalation
|
General Anesthetic
|
Lunan Better Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
10 April 2024
|
16 January 2025
|
| View |
|
DRP-9921-04
|
Sevoflurane
|
Sevosha
|
100%
|
Volatile Liquid for Inhalation
|
General Anesthetic
|
Lunan Better Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
26 April 2024
|
16 January 2025
|
| View |
|
DRP-9975-13
|
Cefuroxime (as axetil)
|
Ecozime
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
28 April 2024
|
01 July 2026
|
| View |
|
HMRP-51-01
|
Vitex negundo L. (Lagundi Leaf)
|
Ragundi Forte
|
600 mg
|
Capsule
|
Herbal Medicine (Anti-Cough/ Anti-asthma)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
10 April 2024
|
11 April 2028
|
| View |
|
HRP-616
|
Petroleum Jelly
|
Unbranded
|
1g / g (100% w/w)
|
Jelly
|
Emollient
|
Dann's Aid Laboratories Inc.
|
Philippines
|
Renewal
|
01 May 2024
|
02 April 2029
|
| View |
|
HRP-616-01
|
Petroleum Jelly
|
Unbranded
|
1g / g (100% w/w)
|
Jelly
|
Emollient
|
Dann’s Aid Lab. Inc
|
Philippines
|
Renewal
|
27 April 2024
|
02 April 2029
|
| View |
|
DRMO-105
|
Medical Grade Oxygen
|
None
|
None
|
None
|
Medical Gas
|
Israel Ma Industrial Gas Corp.
|
Philippines
|
Initial Rx
|
23 April 2024
|
23 April 2029
|